Latisse a Happy Accident for Allergan and Women With Inadequate Eyelashes
Latisse is currently the only FDA-approved treatment for eyelash hypotrichosis, abnormal or inadequate eyelash growth. Latisse is thought to work by increasing the number of eyelashes your eyelid can sprout and extending their growth cycle.
LOS ANGELES, CA, May 26, 2011 /Medical PR News/ -- Allergan seems to have a history of happy accidents.
The specialty pharmaceutical company came
No comments:
Post a Comment